IntrinsicIntrinsic
← Scroll for more →

Financial Statements — PHXE-P

Balance Sheet

(in billions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Cash & Equivalents0.040.070.070.100.060.04
Accounts Receivable0.110.110.080.070.080.04
Inventory0.000.00--------
Total Current Assets0.170.180.170.180.160.10
Total Non-current Assets*2.051.801.631.461.211.03
Total Assets2.221.981.811.641.371.13
Accounts Payable0.150.100.120.140.090.04
Total Current Liabilities0.580.540.420.400.360.26
Long-term Debt1.481.391.531.130.960.85
Total Non-current Liabilities*1.591.501.311.191.020.90
Total Liabilities2.182.041.731.591.381.16
Retained Earnings(0.01)(0.11)0.03-0.00(0.01)(0.03)
Total Stockholder Equity*0.04(0.06)0.080.05(0.01)(0.03)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Total Revenue405.85298.68218.67189.02163.83115.66
Cost of Revenue51.5856.0950.0342.9235.1727.08
Gross Profit354.27242.59168.54146.10128.6788.66
Selling, General & Admin2.764.354.615.546.389.51
Total Operating Expenses190.74150.75125.1099.8381.9749.50
Operating Income163.5491.8343.4546.2746.7039.16
Interest Expense58.3352.5149.5238.8237.0335.85
Net Income105.99(140.12)33.328.4918.705.60
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Operating Cash Flow173.49103.80110.4790.9983.7715.87
Capital Expenditures0.000.151.081.190.220.02
Free Cash Flow*173.49103.66109.3989.7983.5515.84
Investing Cash Flow(294.25)(238.63)(237.46)(256.97)(166.79)(182.27)
Financing Cash Flow87.61139.2197.33200.95108.1580.96
← Scroll for more columns →

* Derived from reported values